1 / 6

Pneumonia Therapeutics Market Development Trends And Key Vendors Analysis During 2020 - 2026

Pneumonia Therapeutics Market Size is expected to exceed USD 2.8 Bn by 2026. Increasing government initiatives for the treatment of pneumonia will significantly accelerate the overall business progression. <br><br>Request sample copy of this Report @ https://www.gminsights.com/request-sample/detail/2029

Kiransable07
Download Presentation

Pneumonia Therapeutics Market Development Trends And Key Vendors Analysis During 2020 - 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pneumonia Therapeutics Market Size Is Expected To Exceed USD 2.8 Bn By 2026: Global Market Insights, Inc. © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  2. Pneumonia Therapeutics Market Scenario: • Pneumonia Therapeutics Market Size is expected to exceed USD 2.8 Bn by 2026. Increasing government initiatives for the treatment of pneumonia will significantly accelerate the overall business progression. • Increasing incidence of pneumococcal disease worldwide will drive the market growth from 2020 to 2026. Pneumococcal disease is caused by Streptococcus pneumonia and can infect the lungs causing blood infection, middle ear infection and bacterial meningitis among others. • Based on the age group, the industry is segmented into pediatric, adult and geriatric. The pediatric segment will exhibit 7.5% CAGR during the analysis period. Children especially with weak immune system are at higher risk of acquiring pneumonia. As child’s immune system is often weak and underdeveloped, the chances of developing pneumonia are much higher. Also, children having cystic fibrosis or asthma problems, and lungs associated disorders further creates higher need for antiviral and antibacterial drugs. Thus, increased risk of pneumonia in pediatric patients augments the segmental growth. © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  3. Continue:- • Based on drug class, the market is segmented into antiviral drugs, antibacterial drugs and antifungal drugs. The antibacterial drugs segment accounted for over 60% revenue share in 2019 and are further classified into quinolones and macrolides among others. Antibacterial drugs are widely used to treat community-acquired pneumonia. • Some major findings of the pneumonia therapeutics market report include: • Increasing incidence of ventilator-associated and community-acquired bacterial pneumonia will boost the pneumonia therapeutics business growth • Rising number of clinical trials for the development of new and more effective drug molecules will enhance the pneumonia therapeutics market growth • Rising awareness among patients regarding pneumonia treatment aids the industry growth • Surging incidence of pneumococcal disease among young population base across the globe will ultimately foster the market growth Request sample copy of this Report @ https://www.gminsights.com/request-sample/detail/2029 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  4. Regional Analysis: • The U.S. pneumonia therapeutics market will witness around 6.3% CAGR and is projected to witness substantial growth during the analysis period. The country growth can be attributed due to increasing geriatric population base, leading to surging demand for pneumonia therapeutic drugs. Additionally, increasing number of hospital admissions for the treatment of pneumonia will enhance the country progression. • Competitive Analysis: • Some of the prominent business players operating in pneumonia therapeutics industry include Abbott Laboratories, Allergan, Bayer, Cipla, Lupin Pharmaceuticals, Mylan, Novartis, Sanofi, Pfizer, Merck, AstraZeneca and GlaxoSmithKline. These market players are focusing on developing new products that helps the firm to expand its overall geographical presence. Request for customization: https://www.gminsights.com/roc/2737 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  5. Latest Research Report on Pneumonia Therapeutics Market @ https://www.gminsights.com/industry-analysis/pneumonia-therapeutics-market Request sample copy of this research report @ https://www.gminsights.com/request-sample/detail/2029 Request for customization: https://www.gminsights.com/roc/2029 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  6. Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com www.gminsights.com

More Related